Targeting high risk (ex-)smokers in Flanders (BE) for lung cancer screenng with low-dose CT-scan. 01/10/2022 - 01/10/2026

Abstract

Lung cancer is the leading cause of cancer death, worldwide and in Belgium. Lung cancer screening (LCS) with low-dose Computed Tomography (LDCT) has been shown to reduce lung cancer specific mortality up to 26% in a high-risk population of current and former smokers. Implementation of LDCT LCS is hence in progress in several European countries, including Belgium. Recruitment of the target group, which is not defined by age and sex but by risk of developing lung cancer, is different than other cancer screening programmes and faces several challenges and barriers to overcome. Our study will A/Prospectively investigate the accrual of eligible high-risk participants in 5 different cohorts of at-risk Flemish citizens: 1/approach by their general practitioner, 2/occupational physician, 3/tobaccologist, 4/a letter joined to their next coming invitation for breast or colon cancer screening and 5/approach of hard-to-reach socio-economic minorities through the Centers for Respiratory Health (Flemish Society of Respiratory Health and Tuberculosis-VRGT) B/Gain insight into the views of relevant stakeholders regarding best practices, barriers, and opportunities for successful implementation of a future lung cancer screening programme in Flanders.

Researcher(s)

Research team(s)

Project type(s)

  • Research Project